Promedior Advances Novel Fibrotic Disease Therapy In Idiopathic Pulmonary Fibrosis
The start-up is also testing the ability of its monocyte-modulating approach to prevent scarring in glaucoma surgery.
The start-up is also testing the ability of its monocyte-modulating approach to prevent scarring in glaucoma surgery.